Pylarify BPA
Ended Awarded Last action
- Contract number
- 36C25223N0480
- Awardee
-
Progenics Pharmaceuticals Inc. UEI YLYKVRPCTCR3 Part of Lantheus Holdings, Inc.
- Awarding agency
-
Veterans Integrated Service Network 12
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $726,144
Award facts
- Contract value 52% obligated
- $1,400,749.44 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- New York, NY 10007, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$10,035 | |
| Funding Only Action | $86,609 | |
| Original award | $649,570 |
About this award
The Department of Veterans Affairs (VA) awarded a Blanket Purchase Agreement (BPA) to Progenics Pharmaceuticals Inc., a subsidiary of Lantheus Holdings, Inc., for the supply of PYLARIFY (piflufolastat F-18), a radioactive diagnostic agent used in positron emission tomography (PET) scans to detect, localize, and image prostate cancer. The BPA, with a ceiling value of $1,400,749.44, is part of the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract and will allow various VA medical facilities, through the Veterans Integrated Service Network (VISN) system, to efficiently procure PYLARIFY and other radiopharmaceuticals for their cancer detection and treatment programs. This contract is not set aside for small businesses.
Quick answers
Who was awarded contract 36C25223N0480?
36C25223N0480 was awarded to Progenics Pharmaceuticals Inc. by Veterans Integrated Service Network 12 (Veterans Health Administration) on July 15, 2023.
How much is contract 36C25223N0480 worth?
The government has obligated $726,144 on 36C25223N0480. Its current value, with exercised options, is $1,400,749.
Is contract 36C25223N0480 an order under another contract?
Yes. 36C25223N0480 is a BPA call under 36F79719D0170-36C25222A0035, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C25223N0480 competed?
The extent of competition for 36C25223N0480 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award